Do you consider SABR for oligometastatic disease in patients with TP53 germline mutation?  

The question at its core is asking would you give RT to a patient with a genetic condition making them more susceptible to RT-induced secondary cancers.  This case discussed TP53 mutation associated with Li-Fraumeni syndrome.However, the case is a patient with oligometastatic disease. This is c...